Can a free-to-choose medicine pathway improve patient treatment? - podcast episode cover

Can a free-to-choose medicine pathway improve patient treatment?

Apr 08, 202413 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

The process of obtaining FDA approval for a new drug costs an estimated $1.8 billion and can take up to 15 years. What’s more, only a small percentage of drugs that undergo human clinical trials are approved. 

To address this, Bartley J Madden, Research Fellow at the Madden Center for Value Creation at Florida Atlantic University, USA, has developed a free to choose medicine (FTCM) model that is currently being considered by US Congress.

Read more in Research outreach

Read the original research: econjwatch.org/science-on-fda-liberalization

For the best experience, listen in Metacast app for iOS or Android